Wellmatix
Wellmatix is an AI-powered Therapeutics discovery company developing next-generation Antibody-Drug Conjugate (ADC) platforms. Its proprietary algorithms accelerate early-stage discovery, reduce costs, and improve success rates in oncology and immunotherapy development.

- Category: Medtech
- Customer segment: B2B, B2G
- Development stage: On market
- Funding stage: Seed
- Founding year: 2021
- Team members: 12
